Trans-endocardial delivery: The importance of the right solution
[ad_1] Peter Altman, CEO of BioCardia, and Matthieu Kalbermatten, CEO of CellProThera, comment on trans-endocardial intramyocardial delivery systems for biotherapeutics to treat heart failure, ischemia, and infarction, and the importance of the…